<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
    <<script src="https://s0.2mdn.net/ads/studio/Enabler.js"></script>
    <title>&nbsp;</title>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="stylesheet" href="style.css">
</head>

<body>
    <div id="container_standard">
        <div id="bg_gradient"></div>
        <div id="foot"></div>
        <div id="wound_halftone"></div>
        <div id="scn1_wound" class="wound"></div>
        <div id="scn1_text" class="ad_text">Proper wound<br/>care requires</div>
        <div id="scn2_wound" class="wound"></div>
        <div id="scn2_text" class="ad_text">complete advancement</div>
        <div id="scn3_wound" class="wound"></div>
        <div id="scn3_text" class="ad_text">of<br/>epithelial edge.<sup>1-2</sup></div>
        <div id="scn4_text" class="ad_text">Why not get there sooner?</div>
        <div id="scn5_graphic"></div>
        <div id="scn5_text" class="ad_text">The only FDA-approved PDGF therapy that can bring closure to patients’ wounds.<sup>3</sup></div>


        <!-- ISI -->
        <!-- ISI -->
        <!-- ISI -->
        <!-- ISI -->
        <div id="isi_standard">
            <div id="isi_scroll">
                <!-- <div id="header_ISI_space"></div> -->

                <p class="bold" style="margin-top: 2px;">Important Safety Information</p>

                <p>REGRANEX◊ gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply when used as an adjunct to, and not a substitute for, good ulcer care practices.</p>
                <ul>
                    <li>The efficacy of REGRANEX gel has not been established for the treatment of pressure ulcers and venous stasis ulcers.</li>
                    <li>The effects of REGRANEX gel on exposed joints, tendons, ligaments, and bone have not been established in humans. </li>
                    <li>REGRANEX gel is a non-sterile, low bioburden preserved product. Therefore, it should not be used in wounds that close by primary intention. </li>
                </ul>

                <p>Malignancies distant from the site of application have been reported in both a clinical study and in posmarketing use. The benefits and risks of REGRANEX gel treatment should be carefully evaluated before prescribing in patients with known malignancy.</p>



                <!-- REFERENCE -->
                <p class="bold">References:</p>
                <p>
                    <ol style="font-weight:bold;">
                        <li><span style="font-weight:normal;">Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management.  <em>Wound Repair Regen</em>. 2003;11(Suppl 1):S1-S8.</span></li>
                        <li><span style="font-weight:normal;">Leaper DJ, Schultz G, Carville K, et al. Extending the TIME concept: what have we learned in the past 10 years? <em>Int Wound J</em> 2012;9(Suppl 2):1-19.</span></li>
                        <li><span style="font-weight:normal;">Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. <em>Diabetes Care.</em> 1998;21:822-827.</span></li>
                    </ol>
                </p>

                <div>
                    <div id="company_logo_standard"></div>
                    <div id="company_logo_standard_tagline">supporting healthcare professionals for over 150 years</div>
                    <p><span style="font-weight: bold;">Advanced Wound Management Smith & Nephew, Inc.</span><br/>
                    5600 Clearfork Main St<br/>
                    Suite 600<br/>
                    Fort Worth, TX 76109<br/>
                    <span id="isi_body_link_site"><a href="http://www.smith-nephew.com/">www.smith-nephew.com</a></span></p>
                    <p>&copy;2019 Smith & Nephew, Inc. All rights reserved.<br/>
                    &#9671;Trademark of Smith & Nephew.<br/>
                    RGEE1-14557-0418RD1</p>
                </div>
            </div>
            <a class="pdf-download" href="https://regranex.com/pdf/PI_Full_Version.pdf"><div id="isi_PI_standard"><span>Click here </span>for prescibing information</div> </a>
        </div>
        <div id="logo_brand_standard"></div>

        <div id="btn_cta_standard">
            <a href="https://regranex.com/mechanism-of-action"><div id="btn_cta_standard_text">See it at work</div>
            <div id="btn_cta_standard_text_carrot"></div>
          </a>

        </div>


        <a href="https://regranex.com/mechanism-of-action"><div id="btn_exit"></div></a>
        <div id="adborder_standard"></div>
    </div>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.20.4/TweenLite.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.20.4/TimelineLite.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.20.4/plugins/CSSPlugin.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.20.4/easing/EasePack.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.20.4/plugins/ScrollToPlugin.min.js"></script>
    <script type="text/javascript" src="SplitText.min.js"></script>

    <script src="script.js"></script>
</body>
</html>
